Foundation for Research and Advocacy in Mental health (FRAMe), Mysore, India.
Schizophrenia Research Foundation, Chennai, India.
Psychogeriatrics. 2021 Mar;21(2):220-238. doi: 10.1111/psyg.12647. Epub 2020 Dec 17.
Despite high burden of dementia in low-and middle-income countries (LMICs), only a small number of clinical trials of psychosocial interventions for persons with dementia (PwD) have been conducted in these settings. It is essential that such trials use appropriate outcome measures that are methodologically robust and culturally appropriate to evaluate the effectiveness of interventions. We carried out a systematic review to examine the evidence base and psychometric properties of measures employed in these studies in LMICs. A systematic search of published literature on randomised controlled trials (RCT) of psychosocial interventions for PwD in LMICs between 2008 and April 2020 was carried out. Measures employed in each of the eligible studies were identified and through a focused search, we further explored the evidence base and psychometric properties employing Terwee criteria. Data extraction and quality appraisal were conducted by two independent reviewers. The review identified 41 measures from 17 RCTS which fulfilled eligibility criteria and they examined effectiveness across the domains of cognition (n = 16), behaviour and psychological symptoms (n = 11) and quality of life (n = 8). Of these 41, we were able to access relevant literature only for 18 and they were subject to psychometric analysis. Psychometric properties of these 18 instruments were at best modest, with Terwee scores ranging from 3 (low) to 15 (moderate). A majority of the studies were from China (n = 5) and Brazil (n = 6). The evidence base for the routinely employed measures in RCTs of non-pharmacological interventions for PwD in LMICs is limited. The quality of adaptation and validation of these instruments is variable and studies are largely uninformative about their psychometric properties and cultural appropriateness to the study setting. There is an urgent need to develop scientifically robust instruments in LMIC settings that can be confidently employed to measure outcomes in trials of psychosocial interventions for PwD.
尽管中低收入国家(LMICs)的痴呆症负担很高,但在这些国家/地区进行的痴呆症患者(PwD)的心理社会干预临床试验数量很少。至关重要的是,此类试验应使用适当的结果测量方法,这些方法在方法上具有稳健性,并且在文化上适合评估干预措施的有效性。我们进行了一项系统审查,以检查这些国家/地区进行的心理社会干预试验中使用的措施的证据基础和心理测量特性。对 2008 年至 2020 年 4 月期间在 LMIC 中进行的针对 PwD 的心理社会干预的随机对照试验(RCT)的已发表文献进行了系统搜索。确定了每个合格研究中使用的措施,并通过重点搜索,我们进一步根据 Terwee 标准探讨了证据基础和心理测量特性。数据提取和质量评估由两名独立的审查员进行。该综述从 17 项 RCT 中确定了 41 项符合资格标准的措施,这些 RCT 研究了认知领域(n = 16)、行为和心理症状(n = 11)以及生活质量(n = 8)的有效性。在这 41 项措施中,我们仅能够访问其中 18 项的相关文献,并且对其进行了心理测量分析。这些 18 种工具的心理测量特性充其量只是适度的,Terwee 得分范围为 3(低)至 15(中)。大多数研究来自中国(n = 5)和巴西(n = 6)。LMIC 中针对 PwD 的非药物干预 RCT 中常规使用的措施的证据基础有限。这些工具的适应性和验证质量各不相同,并且研究很少提供有关其心理测量特性和对研究环境的文化适应性的信息。迫切需要在 LMIC 环境中开发科学上可靠的工具,以便在针对 PwD 的心理社会干预试验中自信地衡量结果。